Trial Profile
A Randomised, Open-Label Preliminary Study To Assess The Effects Of Etanercept 50 mg Once Weekly For 24 Weeks And Etanercept 50 mg Twice Weekly For 12 weeks Reducing To Etanercept 50 mg Once Weekly For 12 weeks On Nail And Skin Symptoms In Patients With Nail Psoriasis And Plaque Psoriasis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis; Psoriasis
- Focus Therapeutic Use
- Acronyms NAIL
- Sponsors Wyeth
- 26 Sep 2012 Results published in the British Journal of Dermatology.
- 29 Jun 2012 Additional trial locations added as reported by European Clinical Trials Database.
- 19 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.